Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |